TNFRSF1A and TNF receptor 1-associated periodic fever syndrome: Prior to treatment, TRAPS patients had higher gene expression of TNFRSF1A, IL-1β, MAPK14, and NFΚB1 compared with healthy donors; however, 15 days after canakinumab treatment, gene expression was completely normalized.